Edwards Lifesciences Corporation
Cash Flow Statement
| Line Item | FY2009 | FY2008 |
|---|---|---|
| Operating Activities | ||
| Net Income | $229.1M | $128.9M |
| Depreciation & Amortization | $58.7M | $55.6M |
| Depreciation | $38.0M | $36.8M |
| Amortization | $20.6M | $19.4M |
| Stock-Based Compensation | $28.3M | $28.7M |
| Net Cash from Operating Activities | $165.3M | $153.2M |
| Investing Activities | ||
| Capital Expenditures | $64.0M | $50.6M |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $40.1M | $58.8M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | $95.5M | $306.5M |
| Net Cash from Financing Activities | $-91.8M | $-134.1M |
| Net Change in Cash | $115.4M | $76.9M |
| Free Cash Flow | $101.3M | $102.6M |